Long-term durability of immune responses to the BNT162b2 and mRNA-1273 vaccines based on dosage, age and sex

Long-term durability of immune responses to the BNT162b2 and mRNA-1273 vaccines based on dosage, age and sex

Abstract The lipid nanoparticle (LNP)-formulated mRNA vaccines BNT162b2 and mRNA-1273 are a widely adopted multi vaccination public health strategy to manage the COVID-19 pandemic. Clinical trial data has described the immunogenicity of the vaccine, albeit within a limited study time frame. Here, we...

Full description

Bibliographic Details
Main Authors: Chapin S. Korosec, Suzan Farhang-Sardroodi, David W. Dick, Sameneh Gholami, Mohammad Sajjad Ghaemi, Iain R. Moyles, Morgan Craig, Hsu Kiang Ooi, Jane M. Heffernan
Format: Article
Language:English
Published: Nature Portfolio 2022-12-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-25134-0

Internet

https://doi.org/10.1038/s41598-022-25134-0

Similar Items